About
Technology
Issues
FAQ
Links
Official Page
Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.